Biotech specialist hits near-record $570m

SV Life Sciences, the biotechnology specialist venture capital firm, has raised the second-biggest venture fund to date in the sector amid a flurry of venture interest in life sciences.

The fund, which the company said was significantly oversubscribed, was closed at $572m (€439m).

WSJ Logo
JPMorgan to Pay $330 Million Over 1MDB TransactionsExternal link

JPMorgan to Pay $330 Million Over 1MDB Transactions